Design, Synthesis, and Pharmacokinetic Evaluation of a Chemical Delivery System for Drug Targeting to Lung Tissue

We espouse the application of a novel chemical delivery system (CDS) approach to a delivery mechanism for drug targeting to lung tissue using the 1,2-dithiolane-3-pentyl moiety of lipoic acid as the “targetor moiety”. The synthesis and the physicochemical and pharma-cokinetic evaluation of a CDS mod...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical sciences Vol. 85; no. 5; pp. 496 - 504
Main Authors Saah, Maurice, Wu, Whei-Mei, Eberst, Kathy, Marvanyos, Ede, Bodor, Nicholas
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.05.1996
John Wiley & Sons, Inc
AMER PHARMACEUTICAL ASSN
Wiley
American Pharmaceutical Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We espouse the application of a novel chemical delivery system (CDS) approach to a delivery mechanism for drug targeting to lung tissue using the 1,2-dithiolane-3-pentyl moiety of lipoic acid as the “targetor moiety”. The synthesis and the physicochemical and pharma-cokinetic evaluation of a CDS modeling the lipoyl and other ester derivatives of chlorambucil (an antineoplastic agent) and cromolyn (a bischromone used in antiasthma prophylaxis) as compared with their respective parent drugs are described. The chlorambucil CDS was synthesized by esterifying the alcohol derivative of lipoic acid with chlorambucil using dicyclohexylcarbodiimide as the coupling agent. The cromolyn CDS was prepared by a multistep synthetic procedure culminating in the reaction of the alkyl bromide derivative of lipoic acid with the disodium salt of the bischromone compound. All the esters were highly lipophilic unlike the parent compounds. The in-vitro kinetic and in-vivo pharmacokinetic studies showed that the respective CDSs were sufficiently stable in buffer and biological media, hydrolyzed rapidly into the respective active parent drugs, and significantly enhanced delivery and retention of the active compound to lung tissue in comparison with the underivatized parent compounds used in conventional therapy.
Bibliography:ark:/67375/WNG-1CKKGK5L-M
istex:22A4369BA73D52E7C2EE3F920F0B90D68987DC1B
ArticleID:JPS8
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3549
1520-6017
DOI:10.1021/js9504200